Protagonist TherapeuticsPTGX
那斯達克 · USD
95.42
-1.06
(-1.10%)
收盤 03/13 03:59 (UTC+8)
03/13 03:59 (UTC+8)
Protagonist TherapeuticsPTGX
95.42
-1.06
(-1.10%)
財務數據
損益表
- -
- 0.60
- 2.55
- 0.04
- 0.05
- 1.71
- 0.28
- 0.06
- 0.05
- 0.07
- -
- -
- 324.92
- -98.37
- 12.19
- 3550.01
- -83.40
- -80.42
- -15.04
- 57.83
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 7,437 | 4,712 | 5,546 | 28,321 | 170,638 | 4,675 | 4,167 | 254,953 | 60,000 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 7,437 | 4,712 | 5,546 | 28,321 | 170,638 | 4,675 | 4,167 | 254,953 | 60,000 | - |
營業費用 | 57,792 | 51,133 | 47,587 | 47,631 | 43,858 | 46,128 | 42,960 | 48,644 | - | 38,326 |
研發費用 | 46,358 | 40,003 | 37,036 | 35,893 | 34,904 | 35,970 | 33,520 | 33,734 | 28,899 | 30,664 |
推銷及管理費用 | 11,434 | 11,130 | 10,551 | 11,738 | 8,954 | 10,158 | 9,440 | 14,910 | 8,052 | 7,662 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -50,355 | -46,421 | -42,041 | -19,310 | 126,780 | -41,453 | -38,793 | 206,309 | 23,049 | -38,326 |
其他收入及費用 | 6,637 | 7,082 | 7,442 | 7,655 | 6,884 | 7,823 | 7,501 | 4,357 | 4,286 | 4,221 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -43,718 | -39,339 | -34,599 | -11,655 | 133,664 | -33,630 | -31,292 | 210,666 | 27,335 | -34,105 |
所得稅 | 666 | - | 172 | - | 1,990 | -420 | -676 | 3,326 | - | - |
稅後純益 | -44,384 | -39,339 | -34,771 | -11,655 | 131,674 | -33,210 | -30,616 | 207,340 | 27,335 | -34,105 |
基本每股稅後盈餘(元) | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 | 3.41 | 0.45 | -0.58 |
稀釋每股稅後盈餘(元) | -0.70 | -0.62 | -0.55 | -0.19 | 2.01 | -0.55 | -0.49 | 3.26 | 0.52 | -0.57 |
基本平均股數(千股) | 64047.00 | 63772.00 | 63510.00 | 62963.00 | 62328.00 | 61767.00 | 61305.00 | 60855.00 | 60387.00 | 59182.00 |
稀釋平均股數(千股) | 64047.00 | 63772.00 | 63510.00 | 62963.00 | 66406.00 | 61767.00 | 61305.00 | 63595.00 | 61796.00 | 59182.00 |
還原基本每股稅後盈餘(元) | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 | 3.41 | 0.45 | -0.58 |
還原稀釋每股稅後盈餘(元) | -0.70 | -0.62 | -0.55 | -0.19 | 2.01 | -0.55 | -0.49 | 3.26 | 0.52 | -0.57 |
還原基本平均股數(千股) | 64,047 | 63,772 | 63,510 | 62,963 | 62,328 | 61,767 | 61,305 | 60,855 | 60,387 | 59,182 |
還原稀釋平均股數(千股) | 64,047 | 63,772 | 63,510 | 62,963 | 66,406 | 61,767 | 61,305 | 63,595 | 61,796 | 59,182 |
EBITDA(千元) | -44,678 | -40,662 | -36,209 | -13,705 | 133,091 | -35,821 | -31,478 | 209,871 | 26,819 | -34,284 |